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Abstract
Increased levels of blood plasma urea were used as phenotypic parameter for establishing
novel mouse models for kidney diseases on the genetic background of C3H inbred mice
in the phenotype-driven Munich ENUmouse mutagenesis project. The phenotypically
recessive mutant line HST011 was established and further analyzed. The causative
mutation was detected in the POU domain, class 3 transcription factor 3 (Pou3f3) gene,
which leads to the amino acid exchange Pou3f3L423P thereby affecting the conserved
homeobox domain of the protein. Pou3f3 homozygous knockout mice are published and
show perinatal death. Line Pou3f3L423P is a viable mouse model harboring a homozygous
Pou3f3mutation. Standardized, systemic phenotypic analysis of homozygous mutants was
carried out in the German Mouse Clinic. Main phenotypic changes were low body weight
and a state of low energy stores, kidney dysfunction and secondary effects thereof including
low bone mineralization, multiple behavioral and neurological defects including locomotor,
vestibular, auditory and nociceptive impairments, as well as multiple subtle changes in
immunological parameters. Genome-wide transcriptome profiling analysis of kidney and
brain of Pou3f3L423P homozygous mutants identified significantly regulated genes as com-
pared to wild-type controls.
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Introduction
Biomedical research with mice as animal models includes the search for and the analysis of
alleles that predispose for or protect against specific diseases. A strategy for the search of novel
disease-related alleles consists of the random chemical mutagenesis of a large number of ani-
mals followed by the systematic screening for clinically relevant disease phenotypes. The alkyl-
ating agent N-ethyl-N-nitrosourea (ENU) is mutagenic for premeiotic spermatogonial stem
cells and allows the production of a large number of randomly mutagenized offspring from
treated males. ENU predominantly induces point mutations [1]. In the phenotype-driven
Munich ENUmouse mutagenesis project using C3HeB/FeJ (C3H) inbred mice as genetic back-
ground, a standardized screening profile of clinical chemical blood plasma parameters was
established for the analysis of the offspring of the mutagenized mice in order to detect pheno-
typic variants [2,3]. Several mutant lines were established showing increased plasma urea levels
as a parameter that is indicative of kidney diseases [4].
Pou3f3 (POU domain, class 3 transcription factor 3, also denominated as Brn1) is an intron-
less gene and is GC rich (74%) throughout the coding region [5,6]. It encodes a 497 amino acid
protein that carries a common DNA binding motif called POU domain (aa 403–462). The
amino acid sequence of POU3F3 is highly conserved in mouse and human thereby showing no
differences in the POU domain but two amino acid exchanges as well as two sites harbouring
glycine stretches with different length in the rest of the sequence (http://www.ensembl.org).
POU transcription factors regulate a variety of developmental processes. POU3F3 plays a role
in neuronal development and is expressed in the developing neocortex, both in the late precur-
sor cells and in the migrating neurons (http://www.uniprot.org). The MGI database (http://
www.informatics.jax.org) harbouring knockout as well as mutant mouse alleles includes two
complete POU3F3 knockouts. Pou3f3 homozygous knockout mice show neonatal mortality.
One-day-old homozygous knockout mice have increased plasma urea and potassium levels
with renal hypoplasia and show developmental defects in the forebrain and the loop of Henle
[7,8].
The ENU mutagenesis-derived recessive mutant mouse line HST011 showing increased
plasma urea levels was analyzed for the causative mutation. After the identification of the caus-
ative mutation in Pou3f3, a standardized, systemic phenotypic analysis of Pou3f3L423P homozy-
gous mutant mice was carried out in the German Mouse Clinic (http://www.mouseclinic.de) to
examine organ systems and/or pathways that may be affected by the Pou3f3mutation as pri-
mary or secondary effects.
Materials and Methods
Animals, Linkage Analysis, and Detection of the Causative Mutation
The recessive mutant line HST011 (= UREHR2) was established in the clinical chemical screen
of the phenotype-based Munich ENUmouse mutagenesis project [9] on the C3HeB/FeJ (C3H)
inbred genetic background by showing increased plasma urea values at the age of three months
(cut-off level: 70 mg/dl = 11.7 mmol/l). Mouse husbandry, breeding, linkage analysis, and
genome-wide mapping were performed as described previously [4]. All mice had free access to
drinking water and a standard rodent diet (V1124; Ssniff, Soest, Germany) ad libitum.
For linkage analysis of the causative mutation, automated DNA extraction from the lysates
was performed using the AGOWAMag Maxi DNA Isolation Kit (AGOWA, Berlin, Germany).
A genome-wide, evenly distributed mapping panel consisting of 158 single nucleotide poly-
morphism (SNP) markers was applied. The markers used are available upon request. Genotyp-
ing using this panel was performed by MassExtend, a MALDI-TOF high-throughput
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genotyping system supplied by Sequenom (San Diego, CA, USA). Additional fine mapping was
performed using further SNP and microsatellite markers. Chromosomal positions of markers
and genes are according to the GRCm38 mouse assembly (http://www.ensembl.org). All genes
which are located in the identified defined chromosomal region were analyzed for published
data about their wild-type and mutant function with respect to their potential impact on renal
function and renal diseases.
Immunohistochemical Analysis
For immunohistochemical analysis, kidneys were fixed with 4% paraformaldehyde in PBS (pH
7.4) via orthograde vascular perfusion, postfixed by immersion in the same fixative for one day
and embedded in paraffin. 3 μm thick paraffin sections were dewaxed and rehydrated, and heat
induced antigen retrieval using Citrate buffer (pH 6.0) was performed. Immunohistochemistry
was performed with a polyclonal guinea pig anti-POU3F3 antiserum (generous gift from
Michael Wegner) [10] and HRP-labeled rabbit anti-guinea pig antibody (Dako, Hamburg, Ger-
many). Immunoreactivity was visualized using 3,3-diaminobenzidine tetrahydrochloride dihy-
drate (DAB) (brown color) and nuclear counterstaining was done with haemalum (blue color).
Phenotypic Analysis in the German Mouse Clinic
Maintenance of the recessive mutant mouse line Pou3f3L423P comprised the repeated backcross
to C3H wild-type mice for more than ten generations leading to the subsequent loss of essen-
tially all non-causative ENUmutations that were not linked to the Pou3f3mutation. The com-
prehensive phenotypic analysis was carried out in the German Mouse Clinic at the Helmholtz
Zentrum München by using standardized examination protocols (http://www.mouseclinic.de).
The analysis covers several hundred parameters in the areas of allergy, behavior, cardiovascular
analysis, clinical chemistry, dysmorphology including bone and cartilage, energy metabolism,
eye analysis and vision, immunology, lung function, molecular phenotyping, neurology, noci-
ception, steroid analysis, and pathology. The complete protocols of the examinations are
described under http://www.mouseclinic.de [11–13].
Pou3f3L423P homozygous mutant mice were analyzed with an age of 8–24 weeks. 27 homo-
zygous mutants and 32 wild-type control littermates were used for phenotypic analyses. The
number of animals analyzed was 13–16 animals per sex and genotype (except of otherwise
stated in the text of the respective Results section).
Mouse husbandry was done under a continuously controlled specific pathogen free (SPF)
hygiene standard according to the FELASA recommendations [14] (http://www.felasa.eu). All
tests were carried out under the approval of the responsible animal welfare authority (Regier-
ung von Oberbayern).
Data are shown as mean ± standard deviation. If not otherwise stated, data were analyzed
using R, a language and environment for statistical computing. Tests for genotype effects were
made by using t-test, Wilcoxon rank sum test, linear models, or ANOVA depending on the
assumed distribution of the parameter and the questions addressed to the data. Significant dif-
ferences are indicated for P< 0.05, 0.01, and 0.001.
Results
Generation of Line Pou3f3L423P and Identification of the Causative
Mutation
The ENU mutagenesis-derived, recessive mutant line HST011 with the G1 male founder ID
20033899 was established on the C3H inbred genetic background by showing increased plasma
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urea values at the age of three months (cut-off level: 70 mg/dl = 11.7 mmol/l) in homozygous
mutant mice. Homozygous mutants of both sexes were viable and fertile. They exhibited a
smaller size but no other grossly apparent phenotype compared to wild-type controls.
Genome-wide linkage analysis of the causative mutation was carried out with phenotypi-
cally homozygous mutant G2 animals derived from the mating of phenotypically homozygous
mutant animals on the inbred C3H genetic background with BALB/c inbred mice and the sub-
sequent intercross of the phenotypically inconspicuous heterozygous mutant G1 mice. Using a
panel of 116 genome-wide polymorphic markers, the mutant phenotype was mapped to a sin-
gle locus on MMU1. Further fine mapping showed the highest linkage for the polymorphic
marker D1Mit212 (40.0 Mb) (http://www.ensembl.org). The candidate gene Pou3f3 was
selected for the sequence analysis, as it is located at 42.7 Mb on chromosome 1, and a published
mutant phenotype has been described with increased plasma urea and potassium levels associ-
ated with renal hypoplasia (http://www.informatics.jax.org). Pou3f3 consists of a single exon
coding for a 497 aa polypeptide. Sequence analysis of Pou3f3 revealed a T!C point mutation
at nt 1268 (ENSMUST00000054883) which leads to the amino acid exchange from leucine to
proline at aa position 423. Therefore, the name of line HST011 was designated as Pou3f3L423P.
The mutation affects the highly conserved DNA binding domain of the protein including aa
403–462. Allelic differentiation of the Pou3f3L423P mutation was carried out by PCR-RFLP as
the point mutation abolished the restriction site for the enzyme SmlI (Fig 1).
To evaluate the impact of the amino acid changing mutation POU3F3L423P on cellular local-
ization and abundance, immunohistochemical localization of POU3F3 in kidneys was per-
formed (Fig 2). In wild-type controls, the transcription factor POU3F3 was immunostained in
nuclei of numerous but not all tubule profiles in weak up to strong staining intensity. The kid-
neys of Pou3f3L423P homozygous mutant mice exhibited similar staining pattern and staining
intensity of POU3F3 compared to wild-type control kidneys.
Phenotypic Analysis in the German Mouse Clinic
Phenotypic analysis of mutant mice in the German Mouse Clinic includes the aim to collect
and deliver by free access systemic phenome data of a high number of mutant mouse lines in a
standardized manner. The complete phenotype reports will be deposited online (http://146.
107.6.187/phenomap/jsp/annotation/public/phenomap.jsf). Pou3f3L423P homozygous mutant
mice were analyzed under the preliminary line name HST011. Compared to wild-type controls,
Pou3f3L423P heterozygous mutant mice showed no differences in the guiding primary symp-
toms of plasma urea value and relative kidney weight. Thus, Pou3f3L423P homozygous mutant
mice were examined in the German Mouse Clinic with wild-type littermates as controls
(S1 Table).
Behavioral and Neurological Analysis
Pou3f3L423P homozygous mutant mice were tested at the age of eight weeks in the open field as
a test of spontaneous unconditioned reactions to a novel environment allowing an evaluation of
exploratory drive, reactivity to novelty and emotionality. Compared to controls, mutant mice
generally showed an increased locomotor activity in this environment with increased distance
moved forward and increased average speed of movement. They spent more time in the aversive
zone of the center and less time in the periphery, however, this may be secondary due to their
increased locomotor activity. In addition, female mutant mice exhibited a decreased rearing
activity (Table 1) that is likely due to the balance and vestibular deficits described below.
Body weights of mutant mice were lower than that of the controls. Already at eight weeks of
age, the mean body weight reduction was 19% in male mutants and 24% in female mutants.
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Significantly altered parameters of the SHIRPA analysis (at 8 weeks) were presence of lacrima-
tion, presence of pelvic elevation during walking, and especially mutant mice showed trunk
curl upon tail suspension and an impaired contact righting reflex when the mice were turned
on their back. The other SHIRPA parameters (locomotor activity, body position, tremor, pal-
pebral closure, defecation and urination during observation, transfer arousal, gait, tail eleva-
tion, startle response, touch escape, positional passivity, limb grasping, pinna reflex, corneal
reflex, evidence of biting and vocalization in and above the arena) were without significant
alterations (Table 2).
Fig 1. Analysis of Pou3f3 in wild-type and Pou3f3L423Pmutant mice. (A) Electropherogram of the
Pou3f3L423P mutation. The box shows the T!C point mutation at nt 1268 (ENSMUST00000054883) from the
wild-type codon leucine (L) to the mutant codon proline (P) at amino acid position 423. (B) Genotyping of mice
by allele-specific PCR-RFLP reaction. SmlI restriction digest of the 460 bp PCR product results in 353 bp and
107 bp fragments of the wild-type allele. Hom, Pou3f3L423P homozygous mutant; Het, Pou3f3L423P
heterozygous mutant; Wt, wild-type; M, pUCMix 8 marker, MBI Fermentas. (C) Partial protein sequence
alignment of the homeobox domain of murine POU3F3 with other species. The underlined amino acid
residue shows the position of the Pou3f3L423P mutation.
doi:10.1371/journal.pone.0150472.g001
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Subsequent measurement of the grip strength (g) for two paws and four paws to evaluate
muscle performance revealed decreased values in the mutants (mean force for 2 paws: 101 ± 19
vs. 120 ± 20 in males, 84 ± 16 vs. 119 ± 16 in females (P = 0.09); mean force for 4 paws:
184 ± 28 vs. 207 ± 17 in males, 152 ± 8 vs. 198 ± 16 in females (P = 0.03); n = 12–16 per geno-
type and sex) which was attributed mainly to the decreased body weight.
Evaluation of motor coordination and balance in three consecutive trials on the accelerating
rotarod at the age of 9 weeks revealed a tendency to increased latencies (sec) on the rod in the
light-weight mutants (127 ± 53 vs. 103 ± 35 in males, 113 ± 55 vs. 97 ± 32 in females (P = 0.89);
n = 12–16 per genotype and sex) and significantly increased passive rotations (45 in three trials
of 27 mutants vs. 35 in three trials of 32 controls (P = 0.02)). The usual improvement in the
performance of the task over the three trials was observed in both genotypes. Since the mutants
showed movement deficits hinting towards coordination or balance deficits, additional tests
especially sensitive to balance impairments were carried out with the same group of mice at the
age of 19 weeks. Balance beam, beam ladder, swim ability as well as gait analysis were per-
formed (n = 10–16 per sex and genotype) with alterations detected in all tests (Table 3).
Fig 2. Immunohistochemical localization of POU3F3 in kidneys. POU3F3 was detected in nuclei of numerous but not all tubule segments with weak up
to strong staining intensity in a wild-type kidney. The immunostaining pattern and staining intensity of POU3F3 in the kidney of a Pou3f3L423P homozygous
mutant mouse was similar to the findings observed in the wild-type control kidney. DAB (brown color); nuclear staining: haemalum (blue color). Age of mice
analyzed: 22 months. Bars represent 100 μm.
doi:10.1371/journal.pone.0150472.g002
Table 1. Open field behavioral analysis of line Pou3f3L423P.
Males Females Genotype: P-value
Parameter Homozygous mutant Wild-type Homozygous mutant Wild-type
Distance traveled–total (cm) 11382 ± 5683 8013 ± 2754 12443 ± 5374 9987 ± 3127 a
Number of rearings—total 6.7 ± 11.0 16.4 ± 23.9 2.3 ± 6.6 47.9 ± 45.3 c
Percent distance in the center—total 18.3 ± 13.0 5.1 ± 5.7 20.3 ± 11.1 9.9 ± 7.0 c
Percent time spent in the center—total 15.0 ± 10.9 3.5 ± 3.8 16.7 ± 9.6 7.0 ± 4.9 c
Whole arena—resting time (sec) 11.1 ± 15.1 24.6 ± 33.8 3.3 ± 4.9 68.5 ± 62.6 c
Whole arena—average speed (cm/sec) 9.6 ± 4.9 6.9 ± 2.6 10.4 ± 4.5 8.9 ± 3.1 a
Latency to enter in the center (sec) 37 ± 59 203 ± 347 89 ± 133 115 ± 129
Number of entries in the center 131 ± 123 26 ± 30 142 ± 92 54 ± 38 c
8-week-old mice were tested in the open field for 20 min. No. per genotype and sex: n = 12–16. Data are presented as mean ± standard deviation.
Significance vs. wild-type controls: a, P < 0.05; c, P < 0.001.
doi:10.1371/journal.pone.0150472.t001
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Morphological analysis of the inner ears using the whole mount clearing method (n = 6 per
genotype) showed abnormal superior semi-circular canal formation of the vestibular organ of
the mutants (Fig 3). The canals appear intact on both sides but the thickness and the curvature
of the superior semi-circular canal is impaired. The side of the superior semi-circular canal
that meets the common crus presents an irregular curvature of the canal that might be respon-
sible for the balance deficits in the mutants.
The prepulse inhibition (PPI) of the acoustic startle reflex test assessed the sensorimotor
gating. Acoustic startle reactivity and prepulse inhibition were significantly decreased in
mutant mice at all sound pressure levels, i.e. startle amplitude at 70, 80, 85, 90, 100, 110 and
120 dB, and prepulse inhibition at 4, 8 and 12 dB prepulse sound pressure level above back-
ground (P< 0.001 for all). The clear reduction of the acoustic startle amplitude suggested
either impaired hearing ability or impaired neuromuscular recruitment. By measuring the
auditory brain stem response (ABR), hearing sensitivity was assessed in a subset of mice (7
male and 3 female mutants as well as 9 male and 5 female controls; 16 weeks of age) by record-
ing the minimum sound pressure required to elicit a physiological response to different audi-
tory stimuli. There were significant (P 0.001) differences at all tone frequencies (6, 12, 18, 24
Table 2. Neurology analysis by modified SHIRPA of line Pou3f3L423P.
Males Females Genotype: P-value
Parameter Homozygous mutant Wild-type Homozygous mutant Wild-type
Body weight (g) 22.4 ± 1.7 27.7 ± 2.2 18.9 ± 1.8 24.9 ± 2.8 c
Locomotor activity (floor squares crossed) 11.1 ± 10.2 7.4 ± 5.8 10.8 ± 7.9 16.4 ± 7.1
Lacrimation 5 of 14 0 of 16 6 of 12 0 of 16 c
Pelvic elevation (more than 5) 4 of 14 0 of 16 3 of 12 0 of 16 b
Tail elevation: horizontal extension 4 of 14 0 of 16 5 of 12 4 of 16 0.06
Trunk curl: present 8 of 14 3 of 16 9 of 12 4 of 16 b
Urination: absent 12 of 14 7 of 16 6 of 12 7 of 16 0.07
Contact righting reflex: absent 11 of 14 2 of 16 8 of 12 1 of 16 c
8-week-old mice were tested. No. per genotype and sex: n = 12–16. Data are presented as mean ± standard deviation (body weight, locomotor activity)
and as exact numbers. Significance vs. wild-type controls: b, P < 0.01; c, P < 0.001.
doi:10.1371/journal.pone.0150472.t002
Table 3. Additional locomotor analysis requiring balancemaintenance of line Pou3f3L423P.
Males Females Genotype: P-value
Test Parameter Homozygous mutant Wild-type Homozygous mutant Wild-type
Balance beam Square, Ø 20 mm (sec) 28.8 ± 8.4 14.0 ± 7.7 24.5 ± 8.8 10.8 ± 4.8 c
Square, Ø 12 mm (sec) 25.6 ± 8.5 13.5 ± 7.7 24.0 ± 12.2 12.1 ± 5.5 c
Round, Ø 22 mm (sec) 22.2 ± 8.2 10.6 ± 5.3 18.6 ± 6.2 9.7 ± 5.4 c
Round, Ø 15 mm (sec) 23.1 ± 8.4 14.6 ± 7.5 21.3 ± 9.7 15.0 ± 7.7 b
Beam ladder Time (sec) 22.6 ± 4.4 17.8 ± 6.1 23.1 ± 3.8 17.1 ± 4.4 c
Fore paw slips (n) 0.5 ± 0.5 0.3 ± 0.5 0.4 ± 0.4 0.2 ± 0.2 a
Hind paw slips (n) 6.6 ± 2.3 3.4 ± 1.5 5.1 ± 1.8 2.4 ± 1.7 c
Stops (n) 4.2 ± 1.1 3.3 ± 1.5 4.1 ± 0.9 2.9 ± 1.0 b
Swim ability Normal (%) 46 100 10 93 c
Irregular (%) 54 0 90 7 c
Analysis was done at the age of 19 weeks. No. per genotype and sex: n = 10–16. Data are presented as mean ± standard deviation (balance beam, beam
ladder). For the swim ability test, the percentages of the mice are shown. Significance vs. wild-type controls: a, P < 0.05; b, P < 0.01; c, P < 0.001.
doi:10.1371/journal.pone.0150472.t003
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and 30 kHz) as well as for the broadband click. Sound pressure thresholds were clearly
increased in both sexes, indicating decreased hearing sensitivity.
Nociception
Analysis of nociception was carried out in 10-week-old mice by using the hot plate assay at
52°C for the detection of altered pain response. The reactions due to thermal pain by shaking
and licking of the hind paws were measured in the mutants and controls (latency in seconds
for shacking of hind paws: 15.4 ± 7.5 vs. 14.3 ± 4.1 in males, 18.8 ± 6.7 vs. 12.5 ± 4.3 in females
(P = 0.02); latency in seconds for licking of hind paws: 24.6 ± 7.4 vs. 23.8 ± 5.7 in males,
28.0 ± 2.9 vs. 21.0 ± 5.7 in females (P = 0.01); n = 13–16 per genotype and sex). Thus, the
female mutants showed a significant hypoalgesia.
Clinical Chemistry and Hematology Analysis
Line Pou3f3L423P was established based on increased plasma urea levels in the homozygous
mutant animals. Clinical chemical analysis of blood plasma at the age of 15 weeks revealed sig-
nificantly increased values for creatinine, urea, chloride, potassium as well as alkaline phospha-
tase, aspartate aminotransferase and lactate dehydrogenase activity, and decreased values for
glucose, albumin, total protein, cholesterol and triglycerides in the mutants (Table 4). In view
of the lower body weight and increased locomotor activity, the plasma parameters with the
Fig 3. Morphological analysis of the inner ears of line Pou3f3L423P.Morphological analysis of the inner
ears using the whole mount clearing method showed abnormal superior semi-circular canal formation in the
homozygous mutants of line Pou3f3L423P. Left picture shows a control inner ear with normal semi-circular
canals. Right picture shows the smaller inner ear of a Pou3f3L423P homozygous mutant animal with abnormal
superior semi-circular canal formation. Red arrow shows the constriction of the superior semi-circular canal.
SSCC: superior semi-circular canal, PSCC: posterior semi-circular canal, ASCC: anterior semi-circular canal.
doi:10.1371/journal.pone.0150472.g003
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decreased values might indicate a state of low energy stores in the mutants. In the hematology
analysis, mutants showed decreased values for red blood cell count, hemoglobin, hematocrit,
mean corpuscular volume and mean corpuscular hemoglobin. Thus, they showed erythropenic
anemia with a trend towards microcytosis. This might be a secondary effect of the azotemia. In
addition, platelets were also decreased, whereas white blood cells were increased in the mutants
(Table 5).
Table 4. Clinical chemical analysis of line Pou3f3L423P.
Males Females Genotype: P-value
Parameter Homozygous mutant Wild-type Homozygous mutant Wild-type
Na+ (mmol/l) 153 ± 1 153 ± 1 151 ± 3 150 ± 4
K+ (mmol/l) 5.1 ± 0.4 4.6 ± 0.3 4.7 ± 0.3 3.9 ± 0.3 c
Ca2+ (mmol/l) 2.4 ± 0.1 2.5 ± 0.1 2.5 ± 0.1 2.4 ± 0.1
Cl- (mmol/l) 109 ± 1 108 ± 2 112 ± 3 110 ± 3 b
Fe (μmol/l) 38.0 ± 3.4 36.8 ± 3.8 40.5 ± 8.8 37.6 ± 3.8
Pi (mmol/l) 1.5 ± 0.3 1.5 ± 0.2 1.7 ± 0.3 2 ± 0.4
Total protein (g/l) 53.2 ± 1.4 56.1 ± 1.8 52.7 ± 1.3 53.5 ± 2.4 c
Albumin (g/l) 29.7 ± 3.4 31.5 ± 1 30.5 ± 2.5 32 ± 1.6 b
Creatinine (μmol/l) 16.5 ± 1.3 15.9 ± 1.0 16.5 ± 2.8 11.1 ± 2.4 c
Urea (mmol/l) 20.8 ± 1.8 10.7 ± 0.9 18.7 ± 2.1 8.7 ± 1.3 c
Cholesterol (mmol/l) 3.5 ± 0.2 4.3 ± 0.4 3.1 ± 0.2 3.3 ± 0.4 c
Triglycerides (mmol/l) 2.2 ± 0.6 3.4 ± 0.8 2.1 ± 0.6 3.0 ± 1.0 c
ALT (U/l) 45 ± 50 33 ± 7 27 ± 5 28 ± 6
AST (U/l) 72 ± 30 51 ± 8 72 ± 22 48 ± 7 c
AP (U/l) 132 ± 14 111 ± 9 148 ± 25 132 ± 14 c
α-Amylase (U/l) 717 ± 86 726 ± 55 694 ± 59 623 ± 59
Glucose (mmol/l) 9.4 ± 1.8 10.6 ± 2.2 10.4 ± 2.0 11.5 ± 1.8 a
LDH (U/l) 250 ± 104 178 ± 38 239 ± 53 181 ± 39 c
Creatinine, plasma creatinine analyzed by the enzymatic method; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AP, alkaline
phosphatase; LDH, lactate dehydrogenase.
15-week-old mice were tested. No. per genotype and sex: n = 13–16. Data are presented as mean ± standard deviation. Significance vs. wild-type
controls: a, P < 0.05; b, P < 0.01; c, P < 0.001.
doi:10.1371/journal.pone.0150472.t004
Table 5. Hematological analysis of line Pou3f3L423P.
Males Females Genotype: P-value
Parameter Homozygous mutant Wild-type Homozygous mutant Wild-type
WBC (103/μl) 8.7 ± 1.5 7.4 ± 1.3 8.7 ± 2.2 7.1 ± 1.4 b
RBC (106/μl) 8.9 ± 0.3 9.5 ± 0.6 9.2 ± 0.3 9.6 ± 0.3 c
PLT (103/μl) 972 ± 74 1093 ± 107 1006 ± 111 1168 ± 93 c
HGB (g/dl) 14.5 ± 0.5 15.6 ± 0.9 15.1 ± 0.5 16.0 ± 0.4 c
HCT (%) 50.2 ± 1.7 54.0 ± 3.3 52.5 ± 1.5 55.6 ± 1.5 c
MCV (fl) 56.2 ± 0.4 56.9 ± 0.7 57.0 ± 0.6 57.8 ± 0.7 c
MCH (pg) 16.2 ± 0.3 16.5 ± 0.4 16.4 ± 0.4 16.6 ± 0.2 a
MCHC (g/dl) 28.8 ± 0.4 28.9 ± 0.6 28.8 ± 0.6 28.8 ± 0.4
WBC, white blood cell count; RBC, red blood cell count; PLT, platelet count; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH,
mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.
15-week-old mice were tested. No. per genotype and sex: n = 13–16. Data are presented as mean ± standard deviation. Significance vs. wild-type
controls: a, P < 0.05; b, P < 0.01; c, P < 0.001.
doi:10.1371/journal.pone.0150472.t005
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Clinical chemical analysis of the plasma parameters of an additional group of homozygous
mutant and wild-type control mice (n = 5–10 per genotype and sex) not transferred to the Ger-
man Mouse Clinic at the age of 12–14 weeks confirmed the results of the GMC analysis at the
age of 15 weeks. Moreover, heterozygous mutants (17 males, 8 females) were also included in
this analysis and showed no significant differences compared to the wild-type controls (data
not shown). In addition, metabolic cage analysis was carried out in these mice at the age of 14–
15 weeks (n = 4–10 per genotype and sex). The mutant mice harbored a lower body weight and
showed an increased urine volume in the males as well as decreased urinary uric acid levels
indicating kidney dysfunction, also together with the other parameters showing altered urine
levels by tendency in both sexes when compared to the controls (Table 6).
In addition, an intraperitoneal glucose tolerance test (IpGTT) was carried out at the age of
12 weeks after food withdrawal overnight (n = 13–16 per genotype and sex). Relative body mass
loss induced by overnight food withdrawal showed no clear genotype effect. In the food-deprived
condition, mutants showed a higher glucose clearance from 30 min after the start of the test com-
pared to the wild-type controls (basal glucose level (mmol/l): 6.1 ± 0.6 vs. 6.2 ± 0.6 in males,
4.9 ± 0.5 vs. 5.0 ± 0.7 in females (P = 0.6); area under the curve (AUC) for the first 30 min:
321 ± 50 vs. 290 ± 64 in males, 219 ± 42 vs. 245 ± 54 in females (P = 0.9); AUC for the remaining
90 min: 447 ± 148 vs. 911 ± 197 in males, 261 ± 73 vs. 422 ± 208 in females (P< 0.001)).
Table 6. Urine analysis of line Pou3f3L423P (in an additional group of mice not transferred to the GermanMouse Clinic).
Males Females
Parameter Homozygous mutant Controls Homozygous mutant Controls
Body weight (g) 20.4 ± 1.4 c 26.3 ± 3.6 18.2 ± 2.2 b 23.3 ± 2.7
Water ad libitum
Water intake (ml/day) 5.9 ± 3.0 4.3 ± 0.7 5.5 ± 1.7 4.9 ± 2.3
Food intake (g/day) 3.5 ± 1.2 3.9 ± 0.6 3.6 ± 0.7 4.2 ± 0.7
Urine volume (ml/day) 1.5 ± 0.7 a 0.9 ± 0.3 1.6 ± 0.5 1.0 ± 0.6
Na+ (μmol/day) 125 ± 47 169 ± 36 170 ± 69 231 ± 67
K+ (μmol/day) 375 ± 114 422 ± 149 505 ± 117 600 ± 232
Ca2+ (μmol/day) 1.5 ± 0.5 1.4 ± 0.6 3.0 ± 0.8 2.0 ± 0.9
Cl- (μmol/day) 217 ± 78 274 ± 73 315 ± 112 395 ± 118
Mg2+ (μmol/day) 9 ± 7 15 ± 9 23 ± 13 22 ± 9
Pi (μmol/day) 50 ± 54 63 ± 47 77 ± 71 99 ± 59
Creatinine-J (μmol/day) 3.5 ± 1.0 4.0 ± 1.0 3.8 ± 1.1 4.9 ± 1.3
Creatinine-E (μmol/day) 2.1 ± 0.5 2.5 ± 0.6 2.5 ± 0.7 3.1 ± 0.9
Urea (mmol/day) 1.2 ± 0.3 1.3 ± 0.4 1.6 ± 0.4 1.8 ± 0.6
Uric acid (nmol/day) 329 ± 94 b 587 ± 154 522 ± 84 b 977 ± 208
Glucose (μmol/day) 1.5 ± 1.1 2.1 ± 1.1 5.0 ± 2.5 a 3.1 ± 0.8
Total protein (mg/day) 5.0 ± 1.7 7.3 ± 3.7 0.9 ± 0.3 2.9 ± 2.1
Albumin (nmol/day) 1.4 ± 0.3 1.9 ± 0.6 2.0 ± 0.2 2.2 ± 0.7
Deprivation of water for 24 h
Loss of body weight (%) 13.2 ± 2.2 b 9.6 ± 1.4 13.4 ± 1.2 c 9.7 ± 1.3
Food intake (g/day) 1.2 ± 0.4 c 2.3 ± 0.3 1.8 ± 0.2 b 2.3 ± 0.3
Urine volume (ml/day) 0.6 ± 0.3 0.5 ± 0.2 0.7 ± 0.1 0.5 ± 0.2
Creatinine-J, creatinine analyzed by Jaffe’s kinetic method; Creatinine-E, creatinine analyzed by the enzymatic method.
The analysis was done under basal conditions and after deprivation of drinking water for 24 h in metabolic cages. 14-15-week-old mice were tested.
Heterozygous mutant and wild-type littermates were used as controls. No. per group and sex: n = 4–10. Data are presented as mean ± standard
deviation. Student’s t-test vs. controls: a P < 0.05, b P < 0.01, c P < 0.001.
doi:10.1371/journal.pone.0150472.t006
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Dysmorphology, Bone and Cartilage
Pou3f3L423P homozygous mutant mice were tested at the age of 10 (morphological analysis), 11
(click box test) and 19 (dual energy X-ray absorption (DXA) and X-ray analysis) weeks. The
systematic morphological investigation via visual inspection (overall body shape, eye, coat,
skin, vibrissae, extremities including limbs, digits and tail, teeth, ears, musculature, skeleton,
neurology/behavior, respiratory system, reproductive system, other aberrant phenotype) found
no genotype-specific differences. Analysis of the hearing ability in 11-week-old mice was exam-
ined by the click box test using a sound of 20 kHz, and the reaction of the animals (n = 13–16
per genotype and sex) was classified into six categories. We observed a decreased hearing reac-
tion in the mutants by trend (P = 0.1 for males, P = 0.3 for females).
DXA (dual energy X-ray absorption) analysis detected significantly decreased values for
bone mineral density (BMD) in male mutants, bone mineral content (BMC) in all mutants,
and bone content in male mutants compared to controls. This might be a secondary effect of
the renal dysfunction leading to the impaired electrolyte balance in the mutant mice which was
revealed in the clinical chemistry analysis. Concurrently body length, body weight, and fat
mass were significantly decreased in mutants (Table 7). X-ray analysis of the skeleton (skull
shape, mandibles, maxilla, teeth, orbit, number of vertebrae, vertebrae shape, number of ribs,
rib shape, scapula, clavicle, pelvis, femur diameter, femur shape, tibia, fibula, humerus, ulna,
radius, number of digits, completeness of digits, joints) found no genotype-specific differences
between mutants and wild-type controls.
Energy Metabolism
Analysis of the energy metabolism was done on 11-week-old mice under ad libitum conditions.
Indirect calorimetry revealed that mutants were considerably underweight and showed a
marked reduction in rectal body temperature. The other effects on energy turnover were con-
founded by the difference in body weight. When adjusted for body weight, significant genotype
effects on residual mean, minimum and maximum oxygen consumption were observed espe-
cially in the female mutants showing a slight hypometabolism. Despite lower metabolic rate,
we observed a mild increase of locomotor activity but not rearing behavior. We could not
detect a significant difference in the respiratory exchange ratio (RER) but the relation between
the levels of oxygen consumption and metabolic fuel utilization indicated that metabolic flexi-
bility may be impaired in mutant mice. At higher levels of VO2, the controls showed a wider
range of respiratory exchange ratios than the mutant mice (not shown). In the determination
Table 7. Dual energy X-ray absorption (DXA) analysis of bone- and weight-related parameters in line Pou3f3L423P.
Males Females
Parameter Homozygous mutant Wild-type Homozygous mutant Wild-type
BMD (mg/cm2) 54 ± 6 b 63 ± 5 54 ± 5 61 ± 6
BMC (mg) 548 ± 79 c 883 ± 246 522 ± 196 a 804 ± 249
Bone content (%) 2.0 ± 0.3 a 2.4 ± 0.6 2.0 ± 0.4 2.3 ± 0.4
Body length (cm) 9.9 ± 0.2 b 10.3 ± 0.2 9.9 ± 0.4 a 10.3 ± 0.4
Body weight (g) 28.1 ± 2.7 c 36.3 ± 3.3 25.2 ± 4.8 c 33.8 ± 6.3
Fat mass (g) 5.8 ± 1.8 c 15.1 ± 5.5 6.6 ± 4.7 b 14.7 ± 7.3
Lean mass (g) 16.0 ± 1.2 14.0 ± 4.0 12.9 ± 1.3 12.7 ± 3.2
BMD, bone mineral density; BMC, bone mineral content.
Analysis was done at the age of 19 weeks. No. per genotype and sex: n = 8–16. Data are presented as mean ± standard deviation. Significance vs. wild-
type controls: a P < 0.05, b P < 0.01, c P < 0.001.
doi:10.1371/journal.pone.0150472.t007
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of body composition by time domain nuclear magnetic resonance (TD-NMR), mutant mice
also showed a significantly lower body weight than control mice. The statistical analysis did
not reveal significant genotype related main effects on body fat content or lean mass when
adjusted for body mass but it was evident that the relation between body weight and fat mass
respectively lean mass was different between control and mutant mice (Table 8).
Immunology
The mice were tested at 15 weeks of age for leukocyte populations in peripheral blood and immu-
noglobulin levels (IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA) as well as rheumatoid factor and anti-
DNA antibodies in blood plasma. Flow cytometry observed a higher frequency of granulocytes as
well as a lower frequency of CD8+ T cells resulting in the tendency of a higher CD4:CD8 ratio in
female mutants. Furthermore, we found higher frequencies of CD44 expressing cells within both
(CD4+ and CD8+) T cell clusters. Only in female mutants we found lower frequencies of B cells
and NK cells and an increased frequency of CD25 expressing cells within the CD4+ T cell cluster
(Table 9). The frequency of granulocytes in blood showed changes which have been described for
various pathological conditions (e.g. tumor development, infection, stress). Thus, the increased
frequency of granulocytes might be a major factor for the changes in the main leukocyte popula-
tions in the mutants. The T cells showed differences in the frequencies of CD44 expressing cells.
The high-surface expression of the CD44 is assigned to activated T cells; alternatively, these cells
might represent cells that arise via physiological homeostatic proliferation [15].
For the immunoglobulin levels, slightly lower levels of immunoglobulins were found in
male mutants compared to controls. Especially, the levels of IgG3 were significantly lower
(data not shown).










Body weight (g) 24.3 ± 1.3 30.7 ± 2.5 20.9 ± 2.1 28.4 ± 3.3 c
Body temperature (°C) 35.7 ± 0.7 36.2 ± 0.4 36.4 ± 0.3 36.8 ± 0.3 b
Food intake (g) 2.8 ± 0.3 3.2 ± 0.8 2.8 ± 0.4 3.6 ± 0.6
Average VO2 consumption (ml/h
animal)
85 ± 4 95 ± 6 81 ± 6 99 ± 7 a
Average RER (VCO2/VO2) 0.89 ± 0.01 0.90 ± 0.04 0.90 ± 0.02 0.92 ± 0.03
Adjusted mean MR (mW) 507 ± 21 508 ± 21 515 ± 23 556 ± 50 0.05
Adjusted RMR (mW) 375 ± 17 383 ± 23 392 ± 11 492 ± 24 c
Average distance (cm/20 min) 843 ± 213 658 ± 86 958 ± 400 810 ± 298 0.06
Average rearings (counts/20 min) 144 ± 59 119 ± 20 144 ± 71 149 ± 69
TD-NMR Body weight (g) 24.8 ± 1.6 30.5 ± 2.6 20.1 ± 2.8 27.4 ± 3.2 c
Fat mass (g) 5.4 ± 0.6 7.8 ± 1.4 4.9 ± 1.1 8.0 ± 1.9
Lean mass (g) 15.8 ± 1 18.9 ± 1.3 12.2 ± 1.5 16.1 ± 1.5 0.06
RER, respiratory exchange ratio; adjusted mean MR, metabolic rate (MR) was adjusted for body mass by subtracting residual MR from modeled mean
expected MR; adjusted RMR, adjusted resting metabolic rate (i.e. lowest MR during the measurement); TD-NMR, time domain nuclear magnetic
resonance.
Analysis was done on 11-week-old mice under ad libitum conditions. No. per genotype and sex: n = 9–16. Substrate utilization rates during indirect
calorimetry were calculated as described [27]. Data are presented as mean ± standard deviation. Significance vs. wild-type controls: a, P < 0.05; b,
P < 0.01; c, P < 0.001.
doi:10.1371/journal.pone.0150472.t008
Generation and Analysis of Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0150472 March 22, 2016 12 / 17
In total, we found multiple changes in the frequencies of leukocyte subset proportions in
peripheral blood. Most of the observed changes were subtle, however, the accumulation of the
immunological findings may suggest a primary or secondary influence of the mutation on the
immune system.
Molecular Phenotyping
Based on the results of the analysis in the German Mouse Clinic as well as on the published
results of Pou3f3 knockout mice [7,8,16], the pathogenic effects of the Pou3f3mutation were
evaluated in brain, kidney and spleen by genome-wide transcriptome profiling analysis using
Illumina MouseRef8 v2.0 Expression Bead Chips. Samples of the three selected organs of four
mutant males were compared to four wild-type males as controls at the age of 24 weeks (in
total 23 experiments as the RNA isolation of one control kidney sample failed).
Statistical analysis of the gene expression patterns [17,18] in the brain identified 104 signifi-
cantly regulated genes in mutants vs. wild-type controls (false discovery rate (FDR) = 0.6%,
fold change> 1.4). The range of the mean log2 ratios was 1.6 to 2.0 for the 7 up-regulated
genes as well as -2.0 to -1.4 for 96 down-regulated genes and -5.0 for Tshb (thyroid stimulating
hormone, beta subunit) as additionally down-regulated gene. The genes are functionally associ-
ated with movement disorders, Huntington’s disease, necrosis and RNA transcription.
Table 9. Immunology analysis of line Pou3f3L423P.
Males Females Genotype: P-value
Parameter Homozygous mutant Wild-type Homozygous mutant Wild-type
CD45+/T cells 33.9 ± 4.4 36.4 ± 3.2 36.6 ± 4.4 39.2 ± 5.2 a
CD45+/CD3+CD4+ 22.0 ± 3.1 23.5 ± 2.5 23.5 ± 2.8 25.1 ± 4.0 0.07
CD45+/CD3+CD8+ 8.9 ± 1.1 9.7 ± 1.0 10.2 ± 1.6 11.4 ± 1.2 b
CD45+/B cells 28.7 ± 3.5 28.7 ± 2.7 28.3 ± 5.0 33.1 ± 5.8 a
CD45+/CD5-NK+ 6.3 ± 1.4 6.9 ± 1.6 4.4 ± 1.0 5.7 ± 1.2 b
CD45+/CD11b+Gr1+ 28.6 ± 6.1 25.6 ± 3.7 28.0 ± 6.1 17.5 ± 5.7 c
CD45+/NK-Gr1-CD11b+ 2.2 ± 0.9 2.7 ± 0.6 2.3 ± 0.7 2.6 ± 1.4
CD45+/CD3+γδTCR+ 0.99 ± 0.2 0.94 ± 0.3 0.99 ± 0.3 0.98 ± 0.3
CD45+/CD5+NK+ 0.06 ± 0.05 0.05 ± 0.03 0.02 ± 0.01 0.02 ± 0.02
CD45+/CD3+CD4+CD25+ 0.89 ± 0.17 0.89 ± 0.14 1.03 ± 0.25 0.94 ± 0.11
CD3+CD4+/CD25+ 4.1 ± 0.6 3.8 ± 0.5 4.4 ± 1.2 3.8 ± 0.4 a
CD3+CD4+/CD62L+ 90.0 ± 3.9 91.3 ± 2.6 85.5 ± 8.5 86.2 ± 5.3
CD3+CD4+/CD44+ 2.5 ± 0.4 2.0 ± 0.3 3.1 ± 0.7 2.3 ± 0.5 c
CD3+CD8+/CD62L+ 97.6 ± 1.0 97.5 ± 0.9 97.2 ± 1.7 97.4 ± 1.1
CD3+CD8+/CD44+ 3.5 ± 0.9 3.3 ± 0.9 2.3 ± 0.8 1.6 ± 0.8 a
B cells/IgD+ 89.3 ± 2.8 88.1 ± 2.8 87.4 ± 2.9 86.6 ± 3.2
B cells/CD5+ 5.3 ± 1.7 5.3 ± 1.0 5.2 ± 2.0 5.1 ± 1.5
B cells/ B220+MHCclassII+ 97.9 ± 1.0 98.2 ± 0.6 93.6 ± 5.1 95.4 ± 3.1
NK+/CD11b+ 9.5 ± 6.3 12.9 ± 6.5 3.4 ± 1.9 3.0 ± 2.4
CD3+ rest 2.9 ± 0.5 3.1 ± 0.4 2.8 ± 0.7 2.7 ± 0.5
ratio CD4: CD8 2.5 ± 0.1 2.4 ± 0.2 2.3 ± 0.2 2.2 ± 0.2
ratio granulocytes: (T cells + B cells) 0.46 ± 0.13 0.40 ± 0.07 0.44 ± 0.13 0.25 ± 0.10 c
ratio T cells: B cells 1.20 ± 0.24 1.28 ± 0.18 1.33 ± 0.29 1.22 ± 0.27
Data are frequencies of main leukocyte subpopulations in peripheral blood (%) measured by flow cytometry.
15-week-old mice were tested. No. per genotype and sex: n = 13–16. Data are presented as mean ± standard deviation. Significance vs. wild-type
controls: a, P < 0.05; b, P < 0.01; c, P < 0.001.
doi:10.1371/journal.pone.0150472.t009
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Statistical analysis of the gene expression patterns in the kidney identified 292 significantly
regulated genes in mutants vs. wild-type controls (FDR = 1.5%, fold change> 1.4). The range
of the mean log2 ratios was 2.0 to 3.4 for the 22 up-regulated genes and -22.8 to -1.7 for the 270
down-regulated genes (with -22.8 to -5.0 for the genes Sycn,Wfdc15b, Cldn10, Shd,Higd1c,
Gpx6, Popdc3, Slc6a12, andMettl7a2). The genes are functionally associated with concentration
of metal ions, lipids, proteins and steroids as well as renal impairment and failure.
Statistical analysis of gene expression patterns in the spleen identified 124 significantly regu-
lated genes (FDR = 0%, fold change> 1.4), all of them were down-regulated. The range of the
mean log2 ratios was -3.9 to -1.5. The genes are functionally associated with inflammatory
response including proliferation/migration/movement of leukocytes, phagocytes, granulocytes
and lymphocytes.
The genes Asah1, Cnot2, Ctps2, Ddx5, Lgsn, Lypla1,Mtmr2 and Rcan1 were down-regulated
in all three organs examined, the genes Armc 8, Atp6ap2, Dars,Hsd11b1, Sh3gl2, Snx14,
Tmem49,Wdr37 and Yme1l1 were down-regulated in both brain and kidney, the gene Sec22a
was down-regulated in both brain and spleen, and the genes Cav2, Cd9, Cyp2b10,Mal, Pira11,
Stap1, Thbs1 and Vps41 were down-regulated in both kidney and spleen. The genes showed a
range of their mean log2 ratios between -2.8 to -1.4. Despite this overlap of differential gene
expression in the organs, necrosis was found as the only gene-specific functional annotation
over-represented in brain and kidney. The other enriched terms were associated with organs-
specific functions.
Discussion
The recessive mutant line HST011 was established on the C3H inbred genetic background
based on increased plasma urea levels, and the causative mutation was identified as Pou3f3L423P
thereby affecting the highly conserved homeobox domain of the protein. Pou3f3 is a transcrip-
tion factor that is expressed in the central nervous system [7,19], the inner ear and some other
organs like the kidney [8] during embryonic development. POU3F3 acts synergistically with
SOX11 and SOX4 (http://www.uniprot.org).
Two complete POU3F3 knockout mutant mouse lines have been described to date. The first
knockout mouse line was established by replacing the gene sequences which encode the first
476 amino acids with a PGK-neo cassette via homologous recombination on an unspecified
genetic background [7]. The second knockout line was also established by using a PGK-neo
cassette for replacing 1.2 kb of the coding region. Functional studies were performed on the
mixed genetic background of 129S4/SvJae × C57BL/6J mice [8]. Heterozygous mutant mice
were reported to be phenotypically normal in both knockout lines. Our heterozygous mutant
mice also showed a grossly normal phenotype. Pou3f3 homozygous knockout mice showed
neonatal mortality. In contrast, Pou3f3L423P homozygous mutant mice are viable and fertile;
however they exhibit a reduced body weight that was about 20–25% less than that of wild-type
controls.
The neonatal homozygous knockout mice showed developmental defects in the forebrain
[7]. In humans, a heterozygous de novo 360 kb deletion in chromosome band 2q12.1 resulting
in the loss of the genes POU3F3 andMRPS9 was identified in a two-year-old boy with mild
dysmorphic features of the head, mild motor delay and mild intellectual disability. The hap-
loinsufficiency of POU3F3 was suggested to be the cause for the aberrant phenotype [20].
Eight-to-24 week-old Pou3f3L423P homozygous mutant mice were phenotypically examined in
the German Mouse Clinic. Our experiments observed deficits in locomotor and coordination
behavior as well as in hearing ability. In the inner ear of rats, Pou3f3 was shown to be expressed
specifically in nonsensory supporting cells and mesenchymal cells of the cochlea at early
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postnatal stages. Neonatal Pou3f3 homozygous knockout mice did not exhibit any abnormality
in the cochlea [21]. The observed morphological alterations of the canals of the vestibular
organ in Pou3f3L423P homozygous mutant mice indicate that Pou3f3 is important for the
proper development of the vestibular organ. The observed hearing impairment also might be
attributed to alterations in the postnatal functional development or maintenance of the inner
ear. Thus, the observed deficits in behavioral and neurological parameters of Pou3f3L423P
homozygous mutant mice might be the consequence of the morphological alterations and neu-
ronal disorganization in the forebrain described previously as well as of the vestibular
dysfunction.
One-day-old Pou3f3 homozygous knockout mice have been described to show a severe
retardation of the normal development of Henle’s loop, the distal convoluted tubule and the
macula densa. They exhibited increased plasma urea and potassium levels with renal hypopla-
sia, and died within 24 hours of birth because of renal failure. In the kidneys of heterozygous
knockout mice, the expression of a number of genes that are specific for the thick ascending
limb of Henle’s loop was reduced including Umod, Nkcc2/Slc12a1, Bsnd, Kcnj1 and Ptger3.
These results demonstrate the crucial role for Pou3f3 in distal tubule formation and function in
the mammalian kidney [8]. We already described the appearance of lower relative kidney
weights in Pou3f3L423P homozygous mutants [4]. Pou3f3L423P homozygous mutant mice
showed impaired renal function indicated by increased plasma levels of urea and creatinine,
alterations in plasma potassium, chloride and protein levels, as well as an increased urine vol-
ume and altered renal excretion of uric acid. X-ray imaging did not reveal skeletal abnormali-
ties, besides decreased body size and body weight, but bone mineral density was found to be
decreased in homozygous mutants. The low bone mineralization may be a secondary effect due
to kidney dysfunction. Altered bone mineralization was already found in previously described
mouse lines showing impaired kidney function due to ENU induced mutations in the genes
Slc12a1 [22] and Umod [23,24]. The observation of erythropenic anemia also may be a second-
ary effect due to kidney dysfunction.
The analysis of energy metabolism in Pou3f3L423P homozygous mutant mice indicated
reduced body temperature and reduced metabolic rate compared to wild-type controls. The
results of the analysis of energy metabolism were supported by the changes of clinical chemical
parameters associated with fat metabolism in homozygous mutants, namely blood lipid levels
and possibly also protein concentrations. A lower body fat content was already found in previ-
ously described mouse lines showing impaired kidney function due to ENU induced mutations
in the genes Slc12a1 [25] and Umod [23,24]. In addition, both Umodmutant mouse lines also
showed a reduced body temperature [24,26].
The multiple subtle changes in immunological parameters may be caused by a primary or
secondary effect of the mutation on the immune system. Genome-wide transcriptome profiling
analysis of brain, kidney and spleen of Pou3f3L423P homozygous mutants identified signifi-
cantly regulated genes as compared to wild-type controls. They have to be examined in detail
in further analyses. In addition, allergy, cardiovascular and steroid analyses of the German
Mouse Clinic revealed no obvious differences of mutant and control mice (data not shown).
Also the histological analysis (HE staining) of the organs of 24-week-old animals showed no
genotype-specific differences (data not shown).
In total, as the first viable mouse line harbouring a Pou3f3mutation, standardized, systemic
phenotypic analysis of Pou3f3L423P homozygous mutants at the age of 2–6 months in the Ger-
man Mouse Clinic revealed major phenotypic changes including low body weight, kidney dys-
function and secondary effects thereof as well as neurological dysfunctions.
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